1. | | Recruiting | Arimidex in McCune Albright Syndrome Condition: McCune-Albright Syndrome |
2. | | Recruiting | AZD5438 in Patients with Advanced Solid Malignancies Condition: advanced, solid, malignancies |
3. | | No longer recruiting | CAFE Comparison of Atypicals in First Episode Conditions: Schizophrenia; Psychotic Disorders; Mental Health; Mental Disorders |
4. | | Recruiting | Comparison of Nolvadex 20 mg and placebo combination to Nolvadex 20 mg and ZD1839 (IRESSA™) 250 mg combination in patients with metastatic breast cancer and estrogen receptor (ER) and/or progesterone (PR) positive tumours Condition: Breast Neoplasms |
5. | | Completed | A comparison of Seroquel vs. Risperidone in Schizophrenia Condition: Schizophrenia |
6. | | Recruiting | Confirmatory Study of Seroquel® in the Treatment of Bipolar Depression Condition: Bipolar Disorder |
7. | | No longer recruiting | Efficacy Study of 6474 to treat Multiple Myeloma Cancer Condition: Multiple Myeloma |
8. | | Recruiting | Enoximone Plus Extended-Release Metoprolol Succinate in Subjects with Advanced Chronic Heart Failure Condition: Heart Failure, Congestive |
9. | | Recruiting | Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome Condition: Zollinger-Ellison Syndrome |
10. | | Suspended | Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects with Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV) Conditions: Carcinoma, Renal Cell; Kidney Neoplasms |
11. | | Recruiting | FASLODEX and AROMASIN in Hormone Receptor Positive Postmenopausal Women with Advanced Breast Cancer Conditions: Breast Neoplasms; Metastases, Neoplasm |
12. | | Recruiting | Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women with Estrogen Receptor Positive Breast Cancer Condition: Breast Cancer |
13. | | No longer recruiting | Iressa Expanded Access Program (EAP) Conditions: Carcinoma, Non-Small-Cell Lung; Metastases, Neoplasm |
14. | | Terminated | Iressa/Docetaxel in Non-Small-Cell Lung Cancer Condition: Non-small cell lung cancer |
15. | | Not yet recruiting | Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects with Advanced or Metastatic Non-Small Cell Lung Cancer Condition: Non-Small-Cell Lung Carcinoma |
16. | | Recruiting | Oral ZD1839 (IRESSA®) Versus Intravenous Docetaxel (TAXOTERE®) in Patients With Non-Small Cell Lung Cancer Condition: Non-Small-Cell Lung Carcinoma |
17. | | Not yet recruiting | Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis (BATT)] Condition: Puberty, Precocious |
18. | | No longer recruiting | A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 Given Orally Once Daily in Subjects with Metastatic Prostate Cancer Conditions: Prostatic Neoplasms; Metastases, Neoplasm |
19. | | Recruiting | Quetiapine Fumarate (SEROQUEL) and Placebo in the Treatment of Acutely Ill Patients with Schizophrenia Condition: Schizophrenia |
20. | | Recruiting | Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients with Schizophrenia Condition: Schizophrenia |
21. | | Recruiting | Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children and Adolescent Patients with Bipolar I Mania Condition: Bipolar Disorder |
22. | | Completed | Reversal of Ventricular Remodeling with Toprol-XL Condition: Heart Failure, Congestive |
23. | | Recruiting | Risedronate Sodium on Bone in Postmenopausal Women with Hormone-Receptor-Positive Early Breast Cancer Condition: Breast Cancer |
24. | | Recruiting | Safety and Effectiveness of NXY-059 for the Treatment of Patients who have Suffered from a Stroke Conditions: Cerebral Stroke; Stroke, Acute; Cerebrovascular Stroke; Ischemic Attack, Transient |
25. | | Completed | Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients with Bipolar Depression Conditions: Bipolar Disorder; Depression, Bipolar |
26. | | Not yet recruiting | Safety of NXY-059 for the Treatment of Patients who have Suffered from a Stroke Condition: Intracerebral Hemorrhage |
27. | | Terminated | Safety, Tolerability and Efficacy of ZD6126 in Combination with Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects with Metastatic Colorectal Cancer. Conditions: Colorectal Neoplasms; Metastases, Neoplasm |
28. | | Recruiting | Seroquel plus Mood Stabilizer Compared to Placebo plus Mood Stabilizer in the Maintenance of Bipolar I Disorder Condition: Bipolar Disorder |
29. | | Recruiting | Study Of Zd1839 (Iressa™) Versus Methotrexate For Previously Treated Patients With Squamous Cell Carcinoma Of The Head And Neck Conditions: Carcinoma, Squamous Cell; Neoplasms, Squamous Cell; Head and Neck Neoplasms |
30. | | Recruiting | A study to determine if antibiotics prevent infection in the pancreas of patients where part of the pancreas has died. Condition: Pancreatitis, Acute Necrotizing |
31. | | Recruiting | Therapy with docetaxel and ZD1839 for Patients who have advanced breast cancer Condition: Breast Neoplasms |
32. | | No longer recruiting | This study is to assess the efficacy and safety of ZD6474 in subjects with metastatic breast cancer Conditions: Breast Neoplasms; Metastases, Neoplasm |
33. | | Completed | This study is to assess the efficacy and safety of ZD6474 in subjects with Non-small cell lung cancer. Conditions: Carcinoma, Non-Small-Cell Lung; Metastases, Neoplasm |
34. | | Completed | This study is to compare the efficacy of ZD6474 and ZD1839 in subjects with NSCLC. Condition: Carcinoma, Non-Small-Cell Lung |
35. | | Recruiting | Trial Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients with Estrogen Receptor (ER) and/or Progesterone Receptor (PgR) Metastatic Breast Cancer Condition: Breast Cancer |
36. | | No longer recruiting | Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support Condition: Pneumonia |
37. | | No longer recruiting | ZD1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer Conditions: stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; Quality of Life |
38. | | No longer recruiting | ZD1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer Conditions: stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer |
39. | | Recruiting | ZD4054 in Pain-free or Mildly symptomatic Patients with Prostate Cancer and Bone Metastases who have Rising Serum Prostate Specific Antigen (PSA) Condition: Prostate Cancer |
40. | | Recruiting | ZD6474 Alone or in Combination with Paclitaxel and Carboplatin in Subjects with Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Condition: Carcinoma, Non-Small-Cell Lung |
41. | | Completed | ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer |